Home › Companies › Protara Therapeutics, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Protara Therapeutics, Inc.’s Form 8-K, filed June 15, 2026 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of June 12, 2026: 8 items on Protara Therapeutics, Inc.’s Form 8-K, filed June 15, 2026: 3 elected · 5 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2025-2026
Explore Protara Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Protara Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 15, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jesse Shefferman | 26,672,259 | -- | -- | 4,241,606 | 14,185,811 | 86% | Elected | — |
| Elect Director: Barry Flannelly, Pharm.D. | 25,409,066 | -- | -- | 5,504,799 | 14,185,811 | 82% | Elected | — |
| Elect Director: Cynthia Smith | 22,371,125 | -- | -- | 8,542,740 | 14,185,811 | 72% | Elected | — |
| 2. Ratification of the Selection of Independent Registered Public Accounting Firm | 45,012,036 | 74,615 | 13,025 | -- | -- | 99.8% | Approved | — |
| 3. Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers | 29,208,205 | 1,656,994 | 48,666 | -- | 14,185,811 | 95% | Approved | — |
| 5. Approval of an Amendment to the Protara Therapeutics, Inc. 2024 Equity Incentive Plan | 18,094,953 | 12,793,033 | 25,879 | -- | 14,185,811 | 59% | Approved | — |
| 6. Approval of an Amendment to the Company's Sixth Amended and Restated Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock from 100,000,000 to 200,000,000 | 42,417,621 | 2,655,416 | 26,639 | -- | -- | 94% | Approved | — |
| 7. Approval of an Amendment to the Company's Sixth Amended and Restated Certificate of Incorporation Allowing Officer Exculpation as Permitted by Delaware Law | 29,642,641 | 1,235,007 | 36,217 | -- | 14,185,811 | 96% | Approved | — |
Source: Protara Therapeutics, Inc., Form 8-K, filed with the SEC on June 15, 2026 — read the filing on EDGAR.
Each item below shows how the 112 asset managers that disclosed a Protara Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Protara Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III directors to the Board of Directors of Protara Therapeutics, Inc., each to hold office until the annual meeting of stockholders in 2029: Barry Flannelly, Pharm.D.
Protara Therapeutics, Inc.’s own tally for this item (“Elect Director: Barry Flannelly, Pharm.D.”): 25,409,066 for, 5,504,799 withheld, per its Form 8-K filed June 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the three persons listed below as Class III directors, each to serve on the Company's Board of Directors until the Company's 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.”
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 5,481,204 for, 714,408 withheld, 13 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,504,419 | 0 | 13 | 3,618 | For |
| BlackRock | 1,457,933 | 0 | 0 | 0 | For |
| Fidelity | 1,022,335 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 199,658 | Withhold |
| Charles Schwab | 147,888 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 143,797 | Withhold |
| American Century | 0 | 0 | 0 | 93,606 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 83,507 | 0 | 0 | 0 | For |
| Equitable | 80,732 | 0 | 0 | 2,510 | For |
| TIAA | 63,860 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 63,000 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 44,029 | Withhold |
| Nationwide | 16,784 | 0 | 0 | 18,617 | Mixed |
| Lincoln Financial | 0 | 0 | 0 | 25,700 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 24,900 | Withhold |
| Global X | 24,135 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,692 | 0 | 0 | 0 | For |
| Pacific Life | 19,494 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 16,701 | Withhold |
| Goldman Sachs | 14,671 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 13,814 | Withhold |
| John Hancock | 0 | 0 | 0 | 13,484 | Withhold |
| AQR | 0 | 0 | 0 | 10,978 | Withhold |
| Voya | 8,624 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 8,362 | Withhold |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
Combines 3 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III directors to the Board of Directors of Protara Therapeutics, Inc., each to hold office until the annual meeting of stockholders in 2029: Cynthia Smith
Protara Therapeutics, Inc.’s own tally for this item (“Elect Director: Cynthia Smith”): 22,371,125 for, 8,542,740 withheld, per its Form 8-K filed June 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the three persons listed below as Class III directors, each to serve on the Company's Board of Directors until the Company's 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.”
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 3,788,754 for, 2,406,850 withheld, 21 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,504,411 | 0 | 21 | 3,618 | For |
| BlackRock | 0 | 0 | 0 | 1,457,933 | Withhold |
| Fidelity | 1,022,335 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 199,658 | Withhold |
| Charles Schwab | 147,888 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 143,797 | Withhold |
| American Century | 0 | 0 | 0 | 93,606 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 83,507 | Withhold |
| Equitable | 0 | 0 | 0 | 83,242 | Withhold |
| TIAA | 63,860 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 63,000 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 44,029 | Withhold |
| Nationwide | 0 | 0 | 0 | 35,401 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 25,700 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 24,900 | Withhold |
| Global X | 24,135 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 0 | 22,692 | Withhold |
| Pacific Life | 0 | 0 | 0 | 19,494 | Withhold |
| Brighthouse | 0 | 0 | 0 | 16,701 | Withhold |
| Goldman Sachs | 14,671 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 13,814 | Withhold |
| John Hancock | 0 | 0 | 0 | 13,484 | Withhold |
| AQR | 0 | 0 | 0 | 10,978 | Withhold |
| Voya | 0 | 0 | 0 | 8,624 | Withhold |
| Jackson National | 0 | 0 | 0 | 8,362 | Withhold |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
Combines 3 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III directors to the Board of Directors of Protara Therapeutics, Inc., each to hold office until the annual meeting of stockholders in 2029: Jesse Shefferman
Protara Therapeutics, Inc.’s own tally for this item (“Elect Director: Jesse Shefferman”): 26,672,259 for, 4,241,606 withheld, per its Form 8-K filed June 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the three persons listed below as Class III directors, each to serve on the Company's Board of Directors until the Company's 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.”
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 5,669,019 for, 526,595 withheld, 11 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,504,421 | 0 | 11 | 3,618 | For |
| BlackRock | 1,457,933 | 0 | 0 | 0 | For |
| Fidelity | 1,022,335 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 199,658 | Withhold |
| Charles Schwab | 147,888 | 0 | 0 | 0 | For |
| Northern Trust | 143,797 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 93,606 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 83,507 | 0 | 0 | 0 | For |
| Equitable | 83,242 | 0 | 0 | 0 | For |
| TIAA | 63,860 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 63,000 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 44,029 | Withhold |
| Nationwide | 16,784 | 0 | 0 | 18,617 | Mixed |
| Lincoln Financial | 25,700 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 24,900 | Withhold |
| Global X | 24,135 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,692 | 0 | 0 | 0 | For |
| Pacific Life | 19,494 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 16,701 | Withhold |
| Goldman Sachs | 14,671 | 0 | 0 | 0 | For |
| State Street | 13,814 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 13,484 | Withhold |
| AQR | 0 | 0 | 0 | 10,978 | Withhold |
| Voya | 8,624 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 8,362 | Withhold |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
96% Approved · of votes cast
Description as filed by funds: Approval of an amendment to our sixth amended and restated certificate of incorporation allowing officer exculpation as permitted by Delaware law
Protara Therapeutics, Inc.’s own tally for this item (“7. Approval of an Amendment to the Company's Sixth Amended and Restated Certificate of Incorporation Allowing Officer Exculpation as Permitted by Delaware Law”): 29,642,641 for, 1,235,007 against — passed, per its Form 8-K filed June 15, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the amendment to the Company's sixth amended and restated certificate of incorporation allowing officer exculpation as permitted by Delaware law.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 6,162,071 for, 33,555 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,506,314 | 1,737 | 0 | 0 | For |
| BlackRock | 1,457,933 | 0 | 0 | 0 | For |
| Fidelity | 1,022,335 | 0 | 0 | 0 | For |
| Dimensional | 199,658 | 0 | 0 | 0 | For |
| Charles Schwab | 147,888 | 0 | 0 | 0 | For |
| Northern Trust | 143,797 | 0 | 0 | 0 | For |
| American Century | 93,606 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,507 | 0 | 0 | 0 | For |
| Equitable | 83,242 | 0 | 0 | 0 | For |
| TIAA | 63,860 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 63,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 44,029 | 0 | 0 | 0 | For |
| Nationwide | 32,794 | 2,607 | 0 | 0 | Mixed |
| Lincoln Financial | 25,700 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,900 | 0 | 0 | 0 | For |
| Global X | 0 | 24,135 | 0 | 0 | Against |
| Bridge Builder Trust | 22,692 | 0 | 0 | 0 | For |
| Pacific Life | 19,494 | 0 | 0 | 0 | For |
| Brighthouse | 16,701 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,671 | 0 | 0 | 0 | For |
| State Street | 13,814 | 0 | 0 | 0 | For |
| John Hancock | 13,484 | 0 | 0 | 0 | For |
| AQR | 10,978 | 0 | 0 | 0 | For |
| Voya | 8,624 | 0 | 0 | 0 | For |
| Jackson National | 8,362 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
94% Approved · of votes cast
Description as filed by funds: Approval of an amendment to our sixth amended and restated certificate of incorporation to increase the number of authorized shares of common stock from 100,000,000 to 200,000,000
Protara Therapeutics, Inc.’s own tally for this item (“6. Approval of an Amendment to the Company's Sixth Amended and Restated Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock from 100,000,000 to 200,000,000”): 42,417,621 for, 2,655,416 against — passed, per its Form 8-K filed June 15, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the amendment to the Company's sixth amended and restated certificate of incorporation to increase the authorized number of the Company's common stock, par value $0.001 per share, from 100,000,000 to 200,000,000.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 6,192,004 for, 3,621 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,504,429 | 3,621 | 0 | 0 | For |
| BlackRock | 1,457,933 | 0 | 0 | 0 | For |
| Fidelity | 1,022,335 | 0 | 0 | 0 | For |
| Dimensional | 199,658 | 0 | 0 | 0 | For |
| Charles Schwab | 147,888 | 0 | 0 | 0 | For |
| Northern Trust | 143,797 | 0 | 0 | 0 | For |
| American Century | 93,606 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,507 | 0 | 0 | 0 | For |
| Equitable | 83,242 | 0 | 0 | 0 | For |
| TIAA | 63,860 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 63,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 44,029 | 0 | 0 | 0 | For |
| Nationwide | 35,401 | 0 | 0 | 0 | For |
| Lincoln Financial | 25,700 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,900 | 0 | 0 | 0 | For |
| Global X | 24,135 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,692 | 0 | 0 | 0 | For |
| Pacific Life | 19,494 | 0 | 0 | 0 | For |
| Brighthouse | 16,701 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,671 | 0 | 0 | 0 | For |
| State Street | 13,814 | 0 | 0 | 0 | For |
| John Hancock | 13,484 | 0 | 0 | 0 | For |
| AQR | 10,978 | 0 | 0 | 0 | For |
| Voya | 8,624 | 0 | 0 | 0 | For |
| Jackson National | 8,362 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
59% Approved · of votes cast
Description as filed by funds: Approval of an amendment to the Protara Therapeutics, Inc. 2024 Equity Incentive Plan
Protara Therapeutics, Inc.’s own tally for this item (“5. Approval of an Amendment to the Protara Therapeutics, Inc. 2024 Equity Incentive Plan”): 18,094,953 for, 12,793,033 against — passed, per its Form 8-K filed June 15, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the amendment to the Protara Therapeutics, Inc. 2024 Equity Incentive Plan, as disclosed in the Company's definitive proxy statement for the Annual Meeting.”
Support: 59% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,504,413 | 3,637 | 0 | 0 | For |
| BlackRock | 1,457,933 | 0 | 0 | 0 | For |
| Fidelity | 0 | 1,022,335 | 0 | 0 | Against |
| Dimensional | 0 | 199,658 | 0 | 0 | Against |
| Charles Schwab | 147,888 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 143,797 | 0 | 0 | Against |
| American Century | 0 | 93,606 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 83,507 | 0 | 0 | 0 | For |
| Equitable | 80,732 | 2,510 | 0 | 0 | For |
| TIAA | 0 | 63,860 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 63,000 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 44,029 | 0 | 0 | Against |
| Nationwide | 16,784 | 18,617 | 0 | 0 | Mixed |
| Lincoln Financial | 0 | 25,700 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 24,900 | 0 | 0 | Against |
| Global X | 24,135 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,692 | 0 | 0 | 0 | For |
| Pacific Life | 19,494 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 16,701 | 0 | 0 | Against |
| Goldman Sachs | 14,671 | 0 | 0 | 0 | For |
| State Street | 0 | 13,814 | 0 | 0 | Against |
| John Hancock | 0 | 13,484 | 0 | 0 | Against |
| AQR | 0 | 10,978 | 0 | 0 | Against |
| Voya | 0 | 8,624 | 0 | 0 | Against |
| Jackson National | 0 | 8,362 | 0 | 0 | Against |
Fund voting reports, all 38 managers: 4,380,666 for, 1,814,959 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Integral Health Asset Management, LLC | 743,885 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 743,885 for.
Combines 4 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement
Protara Therapeutics, Inc.’s own tally for this item (“3. Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers”): 29,208,205 for, 1,656,994 against — passed, per its Form 8-K filed June 15, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement for the Annual Meeting.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,508,047 | 4 | 0 | 0 | For |
| BlackRock | 1,457,933 | 0 | 0 | 0 | For |
| Fidelity | 1,022,335 | 0 | 0 | 0 | For |
| Dimensional | 199,658 | 0 | 0 | 0 | For |
| Charles Schwab | 147,888 | 0 | 0 | 0 | For |
| Northern Trust | 143,797 | 0 | 0 | 0 | For |
| American Century | 0 | 93,606 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 83,507 | 0 | 0 | 0 | For |
| Equitable | 83,242 | 0 | 0 | 0 | For |
| TIAA | 63,860 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 63,000 | 0 | 0 | Against |
| ALPS ETF Trust | 44,029 | 0 | 0 | 0 | For |
| Nationwide | 16,784 | 18,617 | 0 | 0 | Mixed |
| Lincoln Financial | 25,700 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,900 | 0 | 0 | 0 | For |
| Global X | 24,135 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,692 | 0 | 0 | 0 | For |
| Pacific Life | 19,494 | 0 | 0 | 0 | For |
| Brighthouse | 16,701 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,671 | 0 | 0 | 0 | For |
| State Street | 13,814 | 0 | 0 | 0 | For |
| John Hancock | 13,484 | 0 | 0 | 0 | For |
| AQR | 10,978 | 0 | 0 | 0 | For |
| Voya | 8,624 | 0 | 0 | 0 | For |
| Jackson National | 8,362 | 0 | 0 | 0 | For |
Fund voting reports, all 38 managers: 6,017,058 for, 178,568 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 10,277,914 | 0 | 0 | 0 | For |
| Velan Capital Investment Management LP | 2,720,875 | 0 | 0 | 0 | For |
| BlackRock | 1,452,894 | 1,239 | 0 | 0 | For |
| 5AM Venture Management, LLC | 1,369,782 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,146,623 | 0 | 0 | 0 | For |
| Blackstone Inc. | 1,085,038 | 0 | 0 | 0 | For |
| State Street | 894,782 | 774 | 0 | 0 | For |
| AIGH Capital Management LLC | 886,403 | 0 | 0 | 0 | For |
| Integral Health Asset Management, LLC | 743,885 | 0 | 0 | 0 | For |
| J. Goldman & Co LP | 687,727 | 0 | 0 | 0 | For |
| ADAR1 Capital Management, LLC | 457,544 | 0 | 0 | 0 | For |
| Point72 | 374,756 | 0 | 0 | 0 | For |
| Vanguard | 361,441 | 0 | 0 | 0 | For |
| Catalio Capital Management, LP | 250,350 | 0 | 0 | 0 | For |
| Northern Trust | 200,355 | 0 | 0 | 0 | For |
| OPPENHEIMER & CO INC | 185,376 | 0 | 0 | 0 | For |
| CIBC Capital Markets (Europe) S.A. | 171,495 | 0 | 0 | 0 | For |
| CIBC WORLD MARKET INC. | 171,495 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 158,068 | 0 | 0 | 0 | For |
| Charles Schwab | 147,888 | 0 | 0 | 0 | For |
| SUPERSTRING CAPITAL MANAGEMENT LP | 121,457 | 0 | 0 | 0 | For |
| Asset Management One Co., Ltd. | 99,566 | 0 | 0 | 0 | For |
| American Century | 0 | 93,606 | 0 | 0 | Against |
| Alyeska Investment Group, L.P. | 0 | 90,132 | 0 | 0 | Against |
| Renaissance | 87,252 | 0 | 0 | 0 | For |
Institutional-manager reports, all 89 managers: 24,697,857 for, 323,599 against, 178 abstained, 11,135 1 year. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Vote, on an advisory basis, as to whether the stockholder advisory vote to approve the compensation of our named executive officers, (i.e., Proposal 3) should occur every one, two or three years
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| ALPS ETF Trust | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 16,701 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 38 managers: 16,701 for, 5,967,160 1 year, 211,692 3 year, 73 unknown. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 0 | 0 | 0 | 0 | -- |
| Velan Capital Investment Management LP | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| 5AM Venture Management, LLC | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Blackstone Inc. | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Integral Health Asset Management, LLC | 743,885 | 0 | 0 | 0 | For |
| J. Goldman & Co LP | 0 | 0 | 0 | 0 | -- |
| ADAR1 Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| Point72 | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| OPPENHEIMER & CO INC | 0 | 0 | 0 | 0 | -- |
| CIBC Capital Markets (Europe) S.A. | 0 | 0 | 0 | 0 | -- |
| CIBC WORLD MARKET INC. | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Asset Management One Co., Ltd. | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Alyeska Investment Group, L.P. | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 86 managers: 755,020 for, 178 abstained, 20,240,721 1 year, 2,720,875 unknown, 57,765 3 year. Showing the 25 largest; see all in the interactive database.
99.8% Approved · of votes cast
Description as filed by funds: Ratification of the selection by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026
Protara Therapeutics, Inc.’s own tally for this item (“2. Ratification of the Selection of Independent Registered Public Accounting Firm”): 45,012,036 for, 74,615 against — passed, per its Form 8-K filed June 15, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection by the Company's Audit Committee of the Board of Ernst and Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 6,195,626 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,508,051 | 0 | 0 | 0 | For |
| BlackRock | 1,457,933 | 0 | 0 | 0 | For |
| Fidelity | 1,022,335 | 0 | 0 | 0 | For |
| Dimensional | 199,658 | 0 | 0 | 0 | For |
| Charles Schwab | 147,888 | 0 | 0 | 0 | For |
| Northern Trust | 143,797 | 0 | 0 | 0 | For |
| American Century | 93,606 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,507 | 0 | 0 | 0 | For |
| Equitable | 83,242 | 0 | 0 | 0 | For |
| TIAA | 63,860 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 63,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 44,029 | 0 | 0 | 0 | For |
| Nationwide | 35,401 | 0 | 0 | 0 | For |
| Lincoln Financial | 25,700 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,900 | 0 | 0 | 0 | For |
| Global X | 24,135 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,692 | 0 | 0 | 0 | For |
| Pacific Life | 19,494 | 0 | 0 | 0 | For |
| Brighthouse | 16,701 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,671 | 0 | 0 | 0 | For |
| State Street | 13,814 | 0 | 0 | 0 | For |
| John Hancock | 13,484 | 0 | 0 | 0 | For |
| AQR | 10,978 | 0 | 0 | 0 | For |
| Voya | 8,624 | 0 | 0 | 0 | For |
| Jackson National | 8,362 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 56,204,237 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.46% |
| 2 | BlackRock | 2.59% |
| 3 | Fidelity | 1.82% |
| 4 | Dimensional | 0.36% |
| 5 | Charles Schwab | 0.26% |
| 6 | Northern Trust | 0.26% |
| 7 | American Century | 0.17% |
| 8 | QUANTITATIVE MASTER SERIES LLC | 0.15% |
| 9 | Equitable | 0.15% |
| 10 | TIAA | 0.11% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 18.29% |
| 2 | Velan Capital Investment Management LP | 4.84% |
| 3 | BlackRock | 2.59% |
| 4 | 5AM Venture Management, LLC | 2.44% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.04% |
| 6 | Blackstone Inc. | 1.93% |
| 7 | State Street | 1.59% |
| 8 | AIGH Capital Management LLC | 1.58% |
| 9 | Integral Health Asset Management, LLC | 1.32% |
| 10 | J. Goldman & Co LP | 1.22% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| JANUS HENDERSON GROUP Ltd. | 8.36% | 13G |
| BlackRock | 6.04% | 13F |
| Millennium Management | 5.04% | 13F |
| Vanguard Group | 4.26% | 13F |
| Jesse Shefferman | 3.81% | DEF14A |
| Citadel Advisors | 2.19% | 13F |
| Geode Capital | 2.09% | 13F |
| Point72 | 2.05% | 13F |
| State Street | 1.79% | 13F |
| Dimensional Fund Advisors | 0.95% | 13F |
Percentages above are of 56,204,237 shares outstanding, as reported by Protara Therapeutics, Inc. on its Form 10-Q dated May 8, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Protara Therapeutics, Inc.’s 10-Q dated May 8, 2026. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At Protara Therapeutics, Inc.'s shareholder meeting held June 12, 2026, in the 2025-2026 proxy season, 112 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,143 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers, as… — Protara Therapeutics, Inc.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Protara Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 15, 2026.
Protara Therapeutics, Inc. proxy season coverage: 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.